AI Article Synopsis

  • The study aimed to analyze recent pharmacoepidemiological research using Danish registries to understand how real-world drug safety and effectiveness outcomes are assessed and reported.
  • A systematic review of 210 studies from 2018-2019 found that most (96%) focused on clinical outcomes, particularly diagnosis and mortality, with the Danish Health Data Authority as the primary data source.
  • The research highlighted that while a variety of outcomes are supported by these registries, most studies relied on traditional clinical data, with fewer utilizing high-quality social or healthcare cost data.

Article Abstract

Purpose: There is an increasing need for national and international pharmacoepidemiological studies based on high-quality real-world data of which the Danish registries are a valuable source. In lack of a complete overview of which data are used to assess real-world drug safety and effectiveness outcomes, we aimed to map the outcomes, data sources, and the reporting of outcome quality in recent pharmacoepidemiological studies.

Methods: We conducted a systematic mapping review of pharmacoepidemiological studies based on Danish registries investigating drug safety and/or effectiveness, published in the period 2018-2019, identified in PubMed and Scopus. Extraction included: Anatomical Therapeutic Chemical level 2 code for drug exposures, outcomes, outcome data sources, and quality of outcomes.

Results: Of the 210 included studies, 96% used outcomes categorized as Clinical, 4% utilized outcomes categorized as Society-related, 5% used outcomes categorized as Healthcare cost and utilization, and 3% of the studies applied outcomes categorized as Patient-reported in which the percentages are not mutually exclusive. Diagnosis (66%) and Mortality (38%) were the two most utilized subcategories among those categorized as Clinical outcomes. Danish Health Data Authority and Statistics Denmark registries were the most reported outcome data sources (90%). Ninety-six studies (46%) reported one or more quality parameters related to their outcomes of interest with accuracy/validity being the most reported parameter (22%).

Conclusion: The Danish registries support a wide range of outcomes. Across therapeutic areas, most studies investigate traditional clinical outcomes of disease and mortality based on data from a small number of available registries. In contrast, clinical and biochemical databases, despite potentially offering outcomes with high responsiveness, and the high-quality social and healthcare cost registries were rarely used as outcome data sources.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056023PMC
http://dx.doi.org/10.2147/CLEP.S341480DOI Listing

Publication Analysis

Top Keywords

data sources
16
outcomes categorized
16
danish registries
12
outcomes
12
outcome data
12
pharmacoepidemiological studies
8
studies based
8
data
8
drug safety
8
categorized clinical
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!